INOVIQ Limited advised that Tony Di Pietro has resigned as Chief Financial Officer and Company Secretary, effective 11 November 2022. Succeeding Mr. Di Petro will be Mark Edwards, who joins as Chief Financial Officer and Company Secretary, effective 2 November 2022. Mark Edwards B.Acc., CA commences at INOVIQ on 2 November 2022.

He is a highly experienced and capable CFO and Company Secretary with expertise in financial leadership and management, corporate governance, investor relations and corporate transactions. His most recent position was CFO and Company Secretary at Medical Developments International Ltd. for 8 years, where he managed over $60 million in capital raisings, relocated the head office and manufacturing facility, established global infrastructure and operations and oversaw multiple new product launches. Previously he was Head of Finance and Company Secretary at Cogstate Ltd. and an Audit Senior Manager at Ernst & Young (EY) for 14 years, leading and managing professional staff in all aspects of audit, financial reporting, analysis and internal control across Manufacturing, Retail and Consumer Goods sectors, which included ASX listed clients.

Tony Di Pietro has been CFO and Company Secretary of INOVIQ and previously Sienna Cancer Diagnostics for the past eight years. He provided financial oversight for Sienna through its ASX-listing in 2017 through to its acquisition by BARD1 Life Sciences in 2020, and the post-acquisition integration over the past two years. Tony has agreed to assist with the handover to Mark Edwards as well as ensure that all preparations for the upcoming AGM are complete.